cdc25 Phosphatases [fosfatasy cdc25]
- Terms
-
cdc25 fosfatasy
cdc25 fosfatáza
cdc25 fosfatázy
cdc25-fosfatáza
cdc25-fosfatázy
cdc25A-fosfatáza
cdc25B-fosfatáza
cdc25C-fosfatáza
fosfatasa cdc25
fosfatasa cdc25A
fosfatasa cdc25B
fosfatasa cdc25C
fosfatáza cdc25A
fosfatáza cdc25B
fosfatáza cdc25C
fosfatázy cdc25
-
cdc25 Phosphatase
cdc25A Phosphatase
cdc25B Phosphatase
cdc25C Phosphatase
Cell Division Cycle 25B protein
Dual Specificity Phosphatase Cdc25A
Dual Specificity Phosphatase Cdc25B
Dual Specificity Phosphatase Cdc25C
M-Phase Inducer Phosphatase 1
M-Phase Inducer Phosphatase 2
M-Phase Inducer Phosphatase 3
A subclass of dual specificity phosphatases that play a role in the progression of the CELL CYCLE. They dephosphorylate and activate CYCLIN-DEPENDENT KINASES.
- Annotation
- do not confuse with CDC25 GUANINE NUCLEOTIDE EXCHANGE FACTOR
- DUI
- D020687 MeSH Browser
- CUI
- M0328156
- Previous indexing
- Cell Cycle Proteins (1996-1999); Phosphoprotein Phosphatase (1996-1999)
- History note
- 2008(1995)
- Public note
- 2008; see CDC25 PHOSPHATASE 2000-2008; CDC25 PROTEIN (now CDC25 PHOSPHATASE) was indexed under CELL CYCLE PROTEINS 1995-1999 & PHOSPHOPROTEIN PHOSPHATASES 1996-1999; CDC25A PHOSPHATASE & CDC25B PHOSPHATASE were indexed under CDC25 PHOSPHATASES 1999-2007; CDC25C PHOSPHATASE was indexed under CDC25 PHOSPHATASES & CELL CYCLE PROTEINS 2000-2007, under PHOSPHOPROTEIN PHOSPHATASE 1996-1999 & under PROTEINS 1993-1995
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AN
- analysis 1
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 1
- CL
- classification 0
- DF
- deficiency 0
- DE
- drug effects 0
- EC
- economics 0
- GE
- genetics 7
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 16
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PH
- physiology 5
- PO
- poisoning 0
- RE
- radiation effects 3
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UL
- ultrastructure 0
- UR
- urine 0